Meprobamate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Taro Pharmaceutical Industries Ltd.. The primary component is Meprobamate.
Product ID | 52549-4148_a1a2d874-5b9c-4f21-bb21-8757f2468b2a |
NDC | 52549-4148 |
Product Type | Human Prescription Drug |
Proprietary Name | Meprobamate |
Generic Name | Meprobamate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2011-05-23 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA200998 |
Labeler Name | Taro Pharmaceutical Industries Ltd. |
Substance Name | MEPROBAMATE |
Active Ingredient Strength | 400 mg/1 |
DEA Schedule | CIV |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2011-05-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA200998 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-05-23 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA200998 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-05-23 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA200998 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-05-23 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
MEPROBAMATE | 400 mg/1 |
SPL SET ID: | e9aa3d4c-f2e9-4ca9-b563-85fac4024539 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
46708-019 | MEPROBAMATE | MEPROBAMATE |
46708-020 | MEPROBAMATE | MEPROBAMATE |
51672-4147 | Meprobamate | Meprobamate |
51672-4148 | Meprobamate | Meprobamate |
52549-4147 | Meprobamate | Meprobamate |
52549-4148 | Meprobamate | Meprobamate |
55111-640 | Meprobamate | Meprobamate |
55111-641 | Meprobamate | Meprobamate |
62332-019 | Meprobamate | Meprobamate |
62332-020 | Meprobamate | Meprobamate |
69097-974 | Meprobamate | Meprobamate |
69097-975 | Meprobamate | Meprobamate |